Search results for "aggregation."

showing 10 items of 544 documents

In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazone.

2014

<b><i>Background/Aims:</i></b> Organic nitrates represent a group of nitrovasodilators that are clinically used for the treatment of ischemic heart disease. The new compound CLC-3000 is an aminoethyl nitrate (AEN) derivative of pioglitazone, a thiazolidinedione antidiabetic agent combining the peroxisome proliferator-activated receptor γ agonist activity of pioglitazone with the NO-donating activity of the nitrate moiety. <b><i>Methods:</i></b> In vitro and in vivo characterization was performed by isometric tension recording, platelet function, bleeding time and detection of oxidative stress. <b><i>Results:</i></…

DrugBlood PlateletsMaleBleeding TimePlatelet Aggregationmedia_common.quotation_subjectVasodilator Agentsmedicine.disease_causeMitochondria Heartchemistry.chemical_compoundNitrateFibrinolytic AgentsIn vivomedicineAnimalsHumansHypoglycemic AgentsRats WistarAortamedia_commonPharmacologyNitratesPioglitazoneChemistryGeneral MedicineReactive Nitrogen SpeciesIn vitroOrganic nitratesMice Inbred C57BLVasodilationBiochemistryCovalent bondVasoconstrictionThiazolidinedionesReactive Oxygen SpeciesPioglitazoneOxidative stressmedicine.drugPharmacology
researchProduct

Could resveratrol be a useful drug for the treatment of malignant hemopathies?

2013

Resveratrol is a poly-phenol with many beneficial effects: not only as an antioxidant, anti-inflammatory, and antiatherogenic agent, as well as a platelet aggregation inhibitor, but also as an antiproliferative and proapoptotic factor in various types of cancers. There are reviews about the mechanisms responsible for its effects in leukemia and lymphomas, emphasizing the chemosensitizing role of resveratrol, which allows overcoming the multidrug resistance of cancers. The action of resveratrol occurs preferentially on leukemic cells, and not on the normal ones. In addition, it is one of the few drugs that act on leukemic stem cells. If experimental results are promising, its application in …

DrugCancer Researchmedicine.medical_treatmentmedia_common.quotation_subjectAntineoplastic AgentsPharmacologyResveratrolAntioxidantsPatents as Topicchemistry.chemical_compoundNeoplasmsDrug DiscoveryStilbenesmedicineHumansPharmacology (medical)Antiatherogenic agentmedia_commonbusiness.industryGeneral Medicinemedicine.diseaseAntineoplastic Agents PhytogenicBioavailabilityLeukemiaOncologychemistryResveratrolHematologic NeoplasmsPlatelet aggregation inhibitorDrug Therapy CombinationStem cellbusinessAdjuvantRecent patents on anti-cancer drug discovery
researchProduct

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain.

2019

Abstract Background Drug treatment for secondary prevention of cardiovascular disease is recommended by guidelines, but it is not always followed in real life. This study wanted to assess the size of this gap and its impact on mortality in subjects after a cardiovascular event (MACE). Methods Patients with any of MACE in the period from January 1st 2011 to December 31st 2013, and more than one year of follow-up were selected from population of the Valencian Community. Drugs for secondary prevention were antiplatelets, renin-angiotensin system blockers and statins. Assessment of treatment was performed one year after the initial event. Mortality risk was assessed using Cox by the number of d…

DrugMalemedicine.medical_specialtyMedication Therapy Managementmedia_common.quotation_subjectmedicine.medical_treatmentPopulationMyocardial InfarctionAngiotensin-Converting Enzyme InhibitorsDisease030204 cardiovascular system & hematologyRevascularizationRisk Assessment03 medical and health sciencesAngiotensin Receptor Antagonists0302 clinical medicineInternal medicinemedicineSecondary PreventionHumans030212 general & internal medicineMyocardial infarctioneducationStrokemedia_commonAgededucation.field_of_studybusiness.industryConfoundingmedicine.diseaseSurvival AnalysisProfessional Practice GapsStrokeSpainFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessMacePlatelet Aggregation InhibitorsInternational journal of cardiology
researchProduct

Biowaiver monograph for immediate-release solid oral dosage forms: acetylsalicylic acid.

2012

A biowaiver monograph for acetylsalicylic acid (ASA) is presented. Literature and experimental data indicate that ASA is a highly soluble and highly permeable drug, leading to assignment of this active pharmaceutical ingredient (API) to Class I of the Biopharmaceutics Classification System (BCS). Limited bioequivalence (BE) studies reported in the literature indicate that products that have been tested are bioequivalent. Most of the excipients used in products with a marketing authorization in Europe are not considered to have an impact on gastrointestinal motility or permeability. Furthermore, ASA has a wide therapeutic index. Thus, the risks to the patient that might occur if a nonbioequi…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyBioequivalenceMarketing authorizationDosage formDrug StabilityFibrinolytic AgentsAnimalsHumansCyclooxygenase Inhibitorsmedia_commonActive ingredientAspirinChemistryAnti-Inflammatory Agents Non-SteroidalBiopharmaceutics Classification SystemSolubilityTherapeutic EquivalencyPlatelet aggregation inhibitorCaco-2 CellsFibrinolytic agentPlatelet Aggregation InhibitorsTabletsJournal of pharmaceutical sciences
researchProduct

Tendencia en la utilización de antiagregantes en la Comunidad Valenciana (2000-2005)

2007

Beatriz Román Llamosí, Rocío Broseta Solaz, Joan Quiles Izquierdo y Amalia Úbeda Pascual (Amalia.Ubeda@uv.es) Los antiagregantes plaquetarios son fármacos básicos para la prevención de enfermedades isquémicas arteriales. El objetivo de este trabajo es conocer la evolución de su utilización en Atención Primaria en la Comunidad Valenciana durante el periodo 2000-2005. Métodos: Estudio descriptivo del consumo de los antiagregantes plaquetarios (código ATC: B01AC) dispensados con cargo al Sistema Nacional de Salud en la Comunidad Valenciana en el ámbito de Atención Primaria. Datos expresados en dosis diarias definidas (DDD) por 1.000 habitantes y día. Resultados: En 2005 tres fármacos represent…

Drugmedicine.medical_specialtyArterial diseasemedia_common.quotation_subjectlcsh:MedicinePrimary careUNESCO::CIENCIAS MÉDICAS ::Salud públicaInternal medicineAntiagregantes plaquetarios:CIENCIAS MÉDICAS ::Salud pública [UNESCO]MedicineUtilización de medicamentosmedia_commonNational healthbusiness.industryIncidence (epidemiology)lcsh:Public aspects of medicineÁcido acetilsalicícicolcsh:Rlcsh:RA1-1270General MedicineClopidogrelClopidogrelSurgeryPlatelet aggregation inhibitorTriflusalbusinessAntiagregantes plaquetarios; Clopidogrel; Ácido acetilsalicícico; Utilización de medicamentosmedicine.drug
researchProduct

Micellization properties of cardanol as a renewable co-surfactant

2015

With the aim to improve the features of surfactant solutions in terms of sustainability and renewability we propose the use of hydrogenated natural and sustainable plant-derived cardanol as an additive to com- mercial surfactants. In the present study we demonstrated that its addition, in amounts as high as 10%, to commercial surfactants of different charge does not significantly affect surfactant properties. Conversely, the presence of hydrogenated cardanol can strongly affect spectrophotometric determination of CMC if preferential interactions with the dyes used take place. This latter evidence may be profitably exploited in surfactant manufacturing by considering that the concurrent pres…

Dynamic Laser Light Scattering.Sustainable surfactantIONIC SURFACTANTSTETRADECYLDIMETHYLAMINE OXIDEBiochemistryCardanolSurface-Active AgentsPhenolsPulmonary surfactantMoleculeOrganic chemistryFLUORESCENCEPhysical and Theoretical ChemistryMicellesCardanolCetrimoniumChemistrybusiness.industry-PotentialOrganic ChemistryWaterHYDROGENATED CARDANOLOrange OTTensiometryRenewable energyAGGREGATION NUMBERPREMICELLAR AGGREGATIONCetrimonium CompoundsSpectrophotometric determination of CMCGEMINI SURFACTANTSbusinessBEHAVIOROrganic & Biomolecular Chemistry
researchProduct

An unidentified harvestman Leiobunum sp. alarmingly invading Europe (Arachnida: Opiliones)

2007

Etwa seit dem Jahr 2000 breitet sich eine bisher nicht identifizierte Art der Gattung Leiobunum C. L. Koch, 1839 schnell in Mitteleuropa aus. Nachweise ab dem Jahr 2004 sind aus den Niederlanden (wahrscheinlich dem Land des ersten Auftretens in Europa), Deutschland, Österreich und der Schweiz bekannt. Die wahrscheinlich eingeschleppte Art besiedelt bisher lediglich Wände von Gebäuden und seltener felsähnliche Biotope in Wäldern. Adulte Individuen ruhen tagsüber selten einzeln oder in eng geklumpten Gruppen aus Dutzenden bis Hunderten von Individuen an leicht abgedunkelten Stellen in Mauerwinkeln, an glatten Hauswänden und überhängenden Dachtraufen. Jungtiere leben am Boden. Diese Art verfüg…

EcologyPhenologyaggregationIntroduced speciesalien speciesOpilionesBiologybiology.organism_classificationbehaviourintroduced speciestaxonomyHabitatddc:590GenusInsect ScienceWestern europelcsh:Zoologyinvasion strategiescentral Europelcsh:QL1-991LeiobunumEcology Evolution Behavior and SystematicsArachnologische Mitteilungen
researchProduct

The pleiotropic effects of antiplatelet therapies

2019

Percutaneous coronary intervention is the most often used method for coronary revascularization. Stenting restores blood perfusion to ischemic areas, but it also causes mechanical disruption of the atheromatous plaque and the nearby endothelium, stimulating the activation of platelets. In a similar way, platelets are activated by thrombin exposure in the setting of plaque rupture. The interaction between platelets, oxidative stress and inflammation is an important factor determining the extent and severity of vascular dysfunction observed in these settings. Platelets activated by the vessel trauma release inflammatory and mitogenic mediators into the vascular microenvironment, activating le…

EndotheliumPhysiologyInflammation030204 cardiovascular system & hematologyPharmacologymedicine.disease_cause030218 nuclear medicine & medical imagingNitric oxide03 medical and health scienceschemistry.chemical_compound0302 clinical medicineThrombinPhysiology (medical)medicineHumansPlateletEndotheliumPlatelet activationHemostasisbusiness.industryHematologyPlatelet Activationmedicine.anatomical_structurechemistrymedicine.symptomCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsOxidative stressLeukocyte chemotaxismedicine.drugClinical Hemorheology and Microcirculation
researchProduct

Effects of COVID19 pandemic on the Italian power system and possible countermeasures

2021

Abstract The paper analyses the dramatic effects of the first wave of the COVID-19 pandemic on the Italian power system, considering the impacts on load and generation, market issues and ancillary services provision. During the period between March and May 2020, the Italian scenario was considered as exemplary due to the large reduction of loads and thermal generation caused by the hard lockdown across the Country. Italy has experienced the most severe effects of pandemic in terms of increase of death rates and of pressure on the health system as well as severity of the countermeasures. As a domino effect, the total lockdown of one of the most industrialized countries in the world has creat…

Energy Engineering and Power TechnologyFFRArticle99-00Demand responseElectric power systemAggregationBlockchainElectrical and Electronic EngineeringAggregation Blockchain Covid-19. Demand response Electric load FFR Flexibility FRC PandemicResilience (network)Demand responsePandemicSettore ING-INF/03 - TelecomunicazioniPhotovoltaic systemFRC00-01Settore ING-IND/33 - Sistemi Elettrici Per L'EnergiaOpen dataDomino effectPower ratingRisk analysis (engineering)BusinessFlexibilityContingencyCovid-19Electric load
researchProduct

Packet Aggregation in TelosB WSNs: Design, Implementation and Experiments

2016

Master's thesis in Information- and communication technology IKT590 - University of Agder 2016 WSN is an extensive field of research and a core technology which is adopted for monitoring and data assembling, used in various applications. Traditionally in a WSN, communication is performed in the fashion of single packet per transmission which produces high energy consumption and longer delay. Therefore, we introduce a novel approach by designing a system which applies packet aggregation in TelosB sensor motes using Contiki platform. In this approach, we assemble multiple packets together and send them in an aggregated frame towards the sink which can reduce the number of transmissions, energ…

Energy consumptionWSNsDelayVDP::Teknologi: 500::Informasjons- og kommunikasjonsteknologi: 550::Datateknologi: 551IKT590ComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSSpatial and temporalPacket aggregationTelosBDesign and implementationContiki
researchProduct